Cabergoline is an inexpensive, well-tolerated medicine and normalizes IGF-1 levels, particularly used as an add-on therapy to SSA, in a considerable proportion of patients with a moderately elevated IGF-1, which suggests that the combined therapy deserves a more relevant role in the management of acromegaly. This evidence concerns the gene IGF1 and acromegaly.